MedTrace Logo

Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis

NCT02898974 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2020-02-05

Study results available
· View outcomes & findings →

Summary

Medical marijuana is commonly prescribed people with Multiple Sclerosis (MS) for symptom, e.g. spasticity and pain, management. Unfortunately not much is known about its effects outside the treatment for these 2 symptoms. Several previous studies have suggested people with MS using medical marijuana have lower levels of physical disability and improved walking abilities. A major limitation of these previous studies is that the investigators used subjective measures of motor function. In this proposed observational case-control study the investigators plan to objectively measure multiple domains of motor function, such as: fatigue, strength, and walking ability. No marijuana will be brought on to campus or given to participants.

Conditions

Interventions

BEHAVIORAL

Medical Marijuana

To investigate the effects of medical marijuana usage on physical function we will employ an observational case-control design

Sponsors & Collaborators

  • William R. Shaffer, M.D.

    collaborator UNKNOWN

  • Colorado State University

    lead OTHER

Principal Investigators

  • Thorsten Rudroff, Ph.D. · Colorado State University

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02898974 on ClinicalTrials.gov